PL2830589T3 - Preparat nikotynowy - Google Patents

Preparat nikotynowy

Info

Publication number
PL2830589T3
PL2830589T3 PL13712730T PL13712730T PL2830589T3 PL 2830589 T3 PL2830589 T3 PL 2830589T3 PL 13712730 T PL13712730 T PL 13712730T PL 13712730 T PL13712730 T PL 13712730T PL 2830589 T3 PL2830589 T3 PL 2830589T3
Authority
PL
Poland
Prior art keywords
nicotine formulation
nicotine
formulation
Prior art date
Application number
PL13712730T
Other languages
English (en)
Inventor
Fredrik Hübinette
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of PL2830589T3 publication Critical patent/PL2830589T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PL13712730T 2012-03-27 2013-03-15 Preparat nikotynowy PL2830589T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
EP13712730.4A EP2830589B1 (en) 2012-03-27 2013-03-15 Nicotine formulation
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (1)

Publication Number Publication Date
PL2830589T3 true PL2830589T3 (pl) 2019-07-31

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13712730T PL2830589T3 (pl) 2012-03-27 2013-03-15 Preparat nikotynowy

Country Status (21)

Country Link
US (1) US20150096572A1 (pl)
EP (1) EP2830589B1 (pl)
JP (2) JP6412492B2 (pl)
KR (1) KR102038342B1 (pl)
CN (1) CN104411297B (pl)
AU (1) AU2013242200B2 (pl)
BR (1) BR112014023823B1 (pl)
CA (1) CA2868445C (pl)
IN (1) IN2014DN08879A (pl)
MX (1) MX362918B (pl)
MY (1) MY183216A (pl)
NZ (1) NZ626974A (pl)
PL (1) PL2830589T3 (pl)
RS (1) RS58677B1 (pl)
RU (1) RU2625836C2 (pl)
SG (1) SG11201405958RA (pl)
SI (1) SI2830589T1 (pl)
SM (1) SMT201900220T1 (pl)
UA (1) UA116440C2 (pl)
WO (1) WO2013143891A1 (pl)
ZA (1) ZA201407677B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3166563T3 (da) * 2014-07-08 2021-02-15 Fertin Pharma As Oralt administrationssystem omfattende to rum
US11007144B2 (en) 2016-11-15 2021-05-18 Klaria Pharma Holding Ab Pharmaceutical formulation
EP3558267B1 (en) * 2016-12-20 2023-04-26 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201812499D0 (en) * 2018-07-31 2018-09-12 Nicoventures Holdings Ltd Method of making aerosol-forming substrate
WO2020136062A1 (en) * 2018-12-28 2020-07-02 Philip Morris Products S.A. Nicotine formulation comprising metal salt
WO2020141177A1 (en) * 2018-12-31 2020-07-09 Philip Morris Products S.A. Liquid nicotine formulation comprising water-immiscible solvents
GB201912505D0 (en) * 2019-08-30 2019-10-16 Klaria Pharma Holding Ab Pharmaceutical formulation
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) * 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
AU2008311350B2 (en) * 2007-10-11 2014-04-03 Philip Morris Products S.A. Smokeless tobacco product
KR20100095581A (ko) * 2007-12-11 2010-08-31 노파르티스 아게 다-영역 필름
PL2405942T3 (pl) * 2009-03-13 2018-04-30 Excellent Tech Products I Sverige Ab Produkt do podawania doustnego

Also Published As

Publication number Publication date
NZ626974A (en) 2016-09-30
AU2013242200B2 (en) 2017-03-02
SI2830589T1 (sl) 2019-06-28
BR112014023823A2 (pl) 2017-06-20
EP2830589A1 (en) 2015-02-04
KR102038342B1 (ko) 2019-10-30
CA2868445A1 (en) 2013-10-03
JP6412492B2 (ja) 2018-10-24
BR112014023823B1 (pt) 2022-04-26
JP2017226686A (ja) 2017-12-28
CA2868445C (en) 2020-01-28
WO2013143891A1 (en) 2013-10-03
IN2014DN08879A (pl) 2015-05-22
SMT201900220T1 (it) 2019-07-11
SG11201405958RA (en) 2014-10-30
MX2014010760A (es) 2015-03-20
RU2014143003A (ru) 2016-05-20
CN104411297A (zh) 2015-03-11
RU2625836C2 (ru) 2017-07-19
ZA201407677B (en) 2016-05-25
CN104411297B (zh) 2017-10-24
MY183216A (en) 2021-02-18
KR20140140021A (ko) 2014-12-08
HK1205679A1 (en) 2015-12-24
EP2830589B1 (en) 2019-02-13
AU2013242200A1 (en) 2014-10-16
JP2015516948A (ja) 2015-06-18
UA116440C2 (uk) 2018-03-26
US20150096572A1 (en) 2015-04-09
MX362918B (es) 2019-02-26
RS58677B1 (sr) 2019-06-28

Similar Documents

Publication Publication Date Title
ZA201502013B (en) Nicotine composition
PL2836090T3 (pl) Urządzenia generujące aerozol
SG11201406967XA (en) Tobacco substrate
PL2877155T3 (pl) Formulacje opioidowe
IL289157A (en) Opioid compounds
PL2900303T3 (pl) Inhalator
ZA201407677B (en) Nicotine formulation
ZA201306000B (en) Stable formulation
ZA201409020B (en) Pharmaceutical formulation
GB2508825B (en) Composition
PL2856890T3 (pl) Papieros
EP2800474A4 (en) COFFEE FORMULATION
ZA201408114B (en) Oral formulation
AU345797S (en) Cigarette
AU345796S (en) Cigarette
PL2908859T3 (pl) Formulacje arypiprazolu
IL234771B (en) Nicotine formulation
GB201211247D0 (en) Improved formulation
GB201206178D0 (en) Formulations
AU345795S (en) Cigarette
AU345910S (en) Cigarette
GB201206124D0 (en) Match my fit
GB201210088D0 (en) Odontalgic preparation